Society for Cardiovascular Angiography Interventions (SCAI)

The Society for Cardiovascular Angiography and Interventions (SCAI) represents interventional cardiology through education, advocacy, research, setting guidelines and quality patient care. SCAI provides thought leadership in cath lab procedures, new technology and policy.

Thumbnail

More cardiology conferences canceled over COVID-19 concerns

Healthcare conferences all over the world have been delayed or canceled due to the COVID-19 pandemic, and two more significant cancellations have been announced that impact cardiology professionals.

What the COVID-19 pandemic means for cath labs

The COVID-19 pandemic has changed the practice of cardiology as we know it, leading to supplies shortages, delayed procedures, and an at-risk patient population fearful of the road ahead. How has the outbreak affected cath labs?

Thumbnail

As Surgery Gives Way to Transcatheter Procedures, Is the Cardiology Cash Cow in Jeopardy?

With minimally invasive structural procedures crowding out their surgical counterparts, how are physicians and hospitals preparing for the new reality? 

Thumbnail

New guidelines redefine cardiogenic shock

An expert consensus document endorsed by four major cardiology societies redefines cardiogenic shock based on patient descriptions, physical markers and a standardized set of vocabulary.

Thumbnail

Live in Las Vegas: SCAI.19 Expands Focus on Live Cases

SCAI has diversified its planning committees and expanded the focus on live cases for its 2019 scientific sessions, says Program Chair Sunil Rao, MD.

Thumbnail

SCAI publishes consensus document on PFO closure

An expert consensus statement published by the Society for Cardiovascular Angiography and Interventions (SCAI) offers guidance for the safe and effective use of patent foramen ovale (PFO) closure devices to prevent recurrent stroke.

Thumbnail

SCAI chimes in on concerns about paclitaxel devices

The Society for Cardiovascular Angiography and Interventions (SCAI) weighed in on the ongoing debate regarding the long-term safety of paclitaxel-coated balloons and stents on Jan. 25, largely agreeing with the FDA’s stance that the benefits of such devices appear to outweigh the risks until more information becomes available.

Thumbnail

ACC, SCAI and HRS commit to cardiovascular public reporting program

Major cardiovascular societies are increasing their public reporting of data to help patients obtain information on hospitals’ care delivery and improve the quality and cost of care, according to an advisory published online in the Journal of the American College of Cardiology on Nov. 18.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup